LOCALIZATION OF QUINOLINIC ACID IN THE MURINE AIDS MODEL OF RETROVIRUS-INDUCED IMMUNODEFICIENCY - IMPLICATIONS FOR NEUROTOXICITY AND DENDRITIC CELL IMMUNOPATHOGENESIS
Mg. Espey et al., LOCALIZATION OF QUINOLINIC ACID IN THE MURINE AIDS MODEL OF RETROVIRUS-INDUCED IMMUNODEFICIENCY - IMPLICATIONS FOR NEUROTOXICITY AND DENDRITIC CELL IMMUNOPATHOGENESIS, AIDS, 10(2), 1996, pp. 151-158
Objective and design: Using murine AIDS (MAIDS) as a model of retrovir
us-induced immunodeficiency, the aims of this study were (1) to determ
ine the cellular source(s) of quinolinic acid (Quin) with regard to it
s significance as a potential neuroexcitotoxin in AIDS dementia comple
x, and (2) to characterize the relationship between dendritic cell Qui
n immunoreactivity and the histopathological changes associated with t
he progression of disease. Methods: Mice with MAIDS were sacrificed fr
om 1 to 16 weeks post-infection. Temporal and spatial changes in the i
n vivo distribution of Quin at the cellular level were determined by c
arbodiimide-based immunohistochemical methods. Results: Cellular Quin
immunoreactivity was chronically elevated in lymphoid tissues of mice
with MAIDS. In contrast, no cellular Quin immunoreactivity was visible
in the brain parenchyma at any timepoint studied. Conclusion: These f
indings are consistent with the view that select immune cells in the p
eripheral lymphoid tissues may be the primary source of Quin, which ma
y contribute to neurotoxic complications in retrovirus-induced immunod
eficiency syndromes. The predominant Quin immunoreactive cell types ch
anged with the progression of disease. A significant finding was the m
arked increase in the number of Quin immunoreactive dendritic cells in
the early phase of MAIDS, suggesting a relationship between dendritic
cells and Quin in retroviral infection.